Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
SAB Biotherapeutics, Inc. | Director | Common Stock | 2.86M | $2.51M | $0.88 | Nov 24, 2023 | Indirect |
SAB Biotherapeutics, Inc. | Director | Stock Option (right to buy) | 35K | Nov 1, 2024 | Direct | ||
SAB Biotherapeutics, Inc. | Director | Series A-1 Convertible Preferred Stock | 0 | $1,000.00 | Nov 24, 2023 | Indirect |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
SABS | SAB Biotherapeutics, Inc. | Nov 1, 2024 | 2 | $0 | 4 | Nov 5, 2024 | Director |
SABS | SAB Biotherapeutics, Inc. | Nov 24, 2023 | 2 | -$1.8M | 4 | Nov 28, 2023 | Director |
SABS | SAB Biotherapeutics, Inc. | Nov 14, 2023 | 0 | $0 | 3 | Nov 22, 2023 | Director |